All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0822-YF1481 | Anti-Human IZUM04 (XW-561) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-561 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1482 | Anti-Mouse IZUM04 (XW-562) m(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-562 | Rat | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2401 | Anti-Human IZUM04 (XW-561) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-561 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2402 | Anti-Mouse IZUM04 (XW-562) m(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-562 | Rat | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-1122-YF1481 | Anti-IZUM04 TCR-ABR (scFv-TCRα, XW-561) CAR Plasmid, pCDCAR1 | Human | XW-561 | Mouse | scFv-TCRα | Lentiviral vector | T Cell | ||
XS-1122-YF1482 | Anti-IZUM04 TCR-ABR (scFv-TCRα, XW-562) CAR Plasmid, pCDCAR1 | Mouse | XW-562 | Rat | scFv-TCRα | Lentiviral vector | T Cell | ||
XS-1122-YF2401 | Anti-IZUM04 TCR-ABR (scFv-TCRβ, XW-561) CAR Plasmid, pCDCAR1 | Human | XW-561 | Mouse | scFv-TCRβ | Lentiviral vector | T Cell | ||
XS-1122-YF2402 | Anti-IZUM04 TCR-ABR (scFv-TCRβ, XW-562) CAR Plasmid, pCDCAR1 | Mouse | XW-562 | Rat | scFv-TCRβ | Lentiviral vector | T Cell | ||
XS-1122-YF3321 | Anti-IZUM04 TCR-ABR (scFv-CD3γ, XW-561) CAR Plasmid, pCDCAR1 | Human | XW-561 | Mouse | scFv-CD3γ | Lentiviral vector | T Cell | ||
XS-1122-YF3322 | Anti-IZUM04 TCR-ABR (scFv-CD3γ, XW-562) CAR Plasmid, pCDCAR1 | Mouse | XW-562 | Rat | scFv-CD3γ | Lentiviral vector | T Cell | ||
XS-1122-YF4241 | Anti-IZUM04 TCR-ABR (scFv-CD3δ, XW-561) CAR Plasmid, pCDCAR1 | Human | XW-561 | Mouse | scFv-CD3δ | Lentiviral vector | T Cell | ||
XS-1122-YF4242 | Anti-IZUM04 TCR-ABR (scFv-CD3δ, XW-562) CAR Plasmid, pCDCAR1 | Mouse | XW-562 | Rat | scFv-CD3δ | Lentiviral vector | T Cell | ||
XS-1122-YF5161 | Anti-IZUM04 TCR-ABR (scFv-CD3ε, XW-561) CAR Plasmid, pCDCAR1 | Human | XW-561 | Mouse | scFv-CD3ε | Lentiviral vector | T Cell | ||
XS-1122-YF5162 | Anti-IZUM04 TCR-ABR (scFv-CD3ε, XW-562) CAR Plasmid, pCDCAR1 | Mouse | XW-562 | Rat | scFv-CD3ε | Lentiviral vector | T Cell | ||
XS-1122-YF6081 | Anti-IZUM04 (XW-561) h(CD28-CD3ζ) CAR, pAAV | Human | XW-561 | Mouse | scFv-CD28-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF6082 | Anti-IZUM04 (XW-562) h(CD28-CD3ζ) CAR, pAAV | Mouse | XW-562 | Rat | scFv-CD28-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-0123-ZP389 | Anti-IZUM04 (CB-P83) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | CB-P83 | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0123-ZP597 | Anti-IZUM04 (CB-P84) h(scFv-CD3ε) TRuC, pCDTRC1 | Mouse | CB-P84 | Rat | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0323-ZP389 | Anti-IZUM04 (CB-P83 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | CB-P83 | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP597 | Anti-IZUM04 (CB-P84 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Mouse | CB-P84 | Rat | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION